RCEL

Avita Medical Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 0/10
  • Value↓ 0/10
Avita Medical sales and earnings growth
RCEL Growth
Low
  • Revenue Y/Y↑ 11.45%
  • EPS Y/Y↑ 27.20%
  • FCF Y/Y↑ 43.50%
Avita Medical gross and profit margin trends
RCEL Profitability
Neutral
  • Gross margin ↑ 82.10%
  • EPS margin↓ -67.80%
  • ROIC 5Y↓ -65.73%
Avita Medical net debt vs free cash flow
RCEL Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 1.1
  • Interest coverage↓ -8.7

Avita Medical stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Medical Devices stocks